Anders Runo Hilmersson

Yield Life Science AB engages in the investment and development of companies within the pharmaceutical and medical industries. Its portfolio company, Isofol Medical AB, focuses on the development of Modufolin, a rescue therapy for cancer patients. The company was founded by Anders Runo Hilmersson in 1992 and is headquartered in Gothenburg, Sweden.

Yield Life Science (Private Equity) (Yield Life Science-PE) is the private equity subsidiary of Sweden-based Yield AB, controlled by Torgny Prior and Per-Olof Nilsson. Formerly known as Scandinavian Financial Management AB, the firm is based in Gothenburg,and was founded in 2002. The firm provides advisory services related to buyout transactions, growth financing and acquisitions. SFM positions themselves as a regional business incubator.

Yield Life Science AB engages in the investment and development of companies within the pharmaceutical and medical industries. Its portfolio company, Isofol Medical AB, focuses on the development of Modufolin, a rescue therapy for cancer patients. The company was founded by Anders Runo Hilmersson in 1992 and is headquartered in Gothenburg, Sweden.

Yield Life Science AB engages in the investment and development of companies within the pharmaceutical and medical industries. Its portfolio company, Isofol Medical AB, focuses on the development of Modufolin, a rescue therapy for cancer patients. The company was founded by Anders Runo Hilmersson in 1992 and is headquartered in Gothenburg, Sweden.